Zoetis | ZTS - Loan Capital


Zoetis reported $9.05B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
Align Technology USD 0 0 Dec/2024
Bayer EUR 30.68B 1.15B Mar/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Dentsply International USD 2B 10M Jun/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Henry Schein USD 2.3B 27M Jun/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Illumina USD 1.49B 1000K Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
J&J USD 37.34B 183M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Merck USD 51.08B 4.41B Jun/2026
Neogen USD 793.7M 400K Mar/2026
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.28B 337.7M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Quest Diagnostics USD 5.63B 477M Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Sanofi EUR 12.3B 3.42B Mar/2026
Zoetis USD 9.05B 3M Jun/2026